EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Diagnosis of Intestinal Fibrosis in Crohn’s Disease—Present and Future

Sara Jarmakiewicz-Czaja iD, Jolanta Gruszecka iD, Rafał Filip iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25136935 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Sara Jarmakiewicz-Czaja und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health Sciences, Medical College of Rzeszow University, 35-959 Rzeszow, Poland. Hauptthemen laut MEDLINE: Crohn Disease, Fibrosis, Biomarkers. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Crohn’s disease (CD) progresses with periods of remission and exacerbations. During exacerbations, chronic inflammation leads to tissue destruction. As a result, intestinal fibrosis may develop in response to the ongoing inflammatory process. Fibrosis in CD should be considered the result of the response of the intestinal wall (over) to the presence of inflammation in the deep structures of the intestinal wall. In the absence of ideal noninvasive methods, endoscopic evaluation in combination with biopsy, histopathological analysis, stool analysis, and blood analysis remains the gold standard for assessing both inflammation and fibrosis in CD. On the contrary, the ability to identify markers of intestinal fibrosis would help to develop new diagnostic and therapeutic methods to detect early stages of fibrosis. It is speculated that miRNAs may, in the future, become biomarkers for early noninvasive diagnosis in the treatment of intestinal fibrosis. The purpose of this review is to summarise existing diagnostic methods for Crohn’s disease and present recent scientific reports on molecular testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseFibrosisBiomarkersHumansIntestinesMicroRNAs

Stichwörter der Autor:innen

Crohn’s diseasediagnosisintestinal fibrosismiRNAsmolecular testing

Substanzen

BiomarkersMicroRNAs

Autor:innen und Institutionen

  • Institute of Health Sciences, Medical College of Rzeszow University, 35-959 Rzeszow, Poland.
  • Department of Clinical Microbiology, Clinical Hospital No. 2, 35-301 Rzeszow, Poland.
  • Institute of Medicine, Medical College of Rzeszow University, 35-959 Rzeszow, Poland.
  • Department of Gastroenterology with IBD Unit, Clinical Hospital No. 2, 35-301 Rzeszow, Poland.

ORCID-Profile: Sara Jarmakiewicz-Czaja, Jolanta Gruszecka, Rafał Filip

Zitieren

APA

Jarmakiewicz-Czaja, S., Gruszecka, J., & Filip, R. (2024). The Diagnosis of Intestinal Fibrosis in Crohn’s Disease—Present and Future. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25136935

Vancouver

Jarmakiewicz-Czaja S, Gruszecka J, Filip R. The Diagnosis of Intestinal Fibrosis in Crohn’s Disease—Present and Future. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25136935

BibTeX
@article{JarmakiewiczCzaja2024,
  author = {Jarmakiewicz-Czaja, Sara and Gruszecka, Jolanta and Filip, Rafał},
  title = {The Diagnosis of Intestinal Fibrosis in Crohn’s Disease—Present and Future},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25136935}
}
Kostenlos starten →